These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25078137)

  • 21. Genetic inactivation and pharmacological blockade of sigma-1 receptors prevent paclitaxel-induced sensory-nerve mitochondrial abnormalities and neuropathic pain in mice.
    Nieto FR; Cendán CM; Cañizares FJ; Cubero MA; Vela JM; Fernández-Segura E; Baeyens JM
    Mol Pain; 2014 Feb; 10():11. PubMed ID: 24517272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of New Benzylpiperazine Derivatives as σ
    Romeo G; Bonanno F; Wilson LL; Arena E; Modica MN; Pittalà V; Salerno L; Prezzavento O; McLaughlin JP; Intagliata S
    ACS Chem Neurosci; 2021 Jun; 12(11):2003-2012. PubMed ID: 34019387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and synthesis of N‑(benzylpiperidinyl)‑4‑fluorobenzamide: A haloperidol analog that reduces neuropathic nociception via σ
    Déciga-Campos M; Melo-Hernández LA; Torres-Gómez H; Wünsch B; Schepmann D; González-Trujano ME; Espinosa-Juárez J; López-Muñoz FJ; Navarrete-Vázquez G
    Life Sci; 2020 Mar; 245():117348. PubMed ID: 31981633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and structure-activity relationship study of a new series of selective σ(1) receptor ligands for the treatment of pain: 4-aminotriazoles.
    Díaz JL; Christmann U; Fernández A; Torrens A; Port A; Pascual R; Álvarez I; Burgueño J; Monroy X; Montero A; Balada A; Vela JM; Almansa C
    J Med Chem; 2015 Mar; 58(5):2441-51. PubMed ID: 25658964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Examination of the Novel Sigma-1 Receptor Antagonist, SI 1/28, for Antinociceptive and Anti-allodynic Efficacy against Multiple Types of Nociception with Fewer Liabilities of Use.
    Wilson LL; Eans SO; Ramadan-Siraj I; Modica MN; Romeo G; Intagliata S; McLaughlin JP
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological evaluation of novel sigma-1 receptor antagonists based on pyrimidine scaffold as agents for treating neuropathic pain.
    Lan Y; Chen Y; Cao X; Zhang J; Wang J; Xu X; Qiu Y; Zhang T; Liu X; Liu BF; Zhang G
    J Med Chem; 2014 Dec; 57(24):10404-23. PubMed ID: 25420090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimization of bifunctional piperidinamide derivatives as σ
    Xiong J; Zhuang T; Ma Y; Xu J; Ye J; Ma R; Zhang S; Liu X; Liu BF; Hao C; Zhang G; Chen Y
    Eur J Med Chem; 2021 Dec; 226():113879. PubMed ID: 34628236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological profiling of sigma 1 receptor ligands by novel receptor homomer assays.
    Yano H; Bonifazi A; Xu M; Guthrie DA; Schneck SN; Abramyan AM; Fant AD; Hong WC; Newman AH; Shi L
    Neuropharmacology; 2018 May; 133():264-275. PubMed ID: 29407216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting immune-driven opioid analgesia by sigma-1 receptors: Opening the door to novel perspectives for the analgesic use of sigma-1 antagonists.
    Tejada MÁ; Montilla-García Á; González-Cano R; Bravo-Caparrós I; Ruiz-Cantero MC; Nieto FR; Cobos EJ
    Pharmacol Res; 2018 May; 131():224-230. PubMed ID: 29454675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of a new series of hexahydro-2H-pyrano[3,2-c]quinolines as novel selective σ1 receptor ligands.
    Díaz JL; Christmann U; Fernández A; Luengo M; Bordas M; Enrech R; Carro M; Pascual R; Burgueño J; Merlos M; Benet-Buchholz J; Cerón-Bertran J; Ramírez J; Reinoso RF; Fernández de Henestrosa AR; Vela JM; Almansa C
    J Med Chem; 2013 May; 56(9):3656-65. PubMed ID: 23560650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sigma-1 receptor: A drug target for the modulation of neuroimmune and neuroglial interactions during chronic pain.
    Ruiz-Cantero MC; González-Cano R; Tejada MÁ; Santos-Caballero M; Perazzoli G; Nieto FR; Cobos EJ
    Pharmacol Res; 2021 Jan; 163():105339. PubMed ID: 33276102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel object recognition test as an alternative approach to assessing the pharmacological profile of sigma-1 receptor ligands.
    Szczepańska K; Bojarski AJ; Popik P; Malikowska-Racia N
    Pharmacol Rep; 2023 Oct; 75(5):1291-1298. PubMed ID: 37572216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological evaluation of a novel sigma-1 receptor antagonist based on 3,4-dihydro-2(1H)-quinolinone scaffold as a potential analgesic.
    Lan Y; Chen Y; Xu X; Qiu Y; Liu S; Liu X; Liu BF; Zhang G
    Eur J Med Chem; 2014 May; 79():216-30. PubMed ID: 24735647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Operant self-administration of a sigma ligand improves nociceptive and emotional manifestations of neuropathic pain.
    Bura AS; Guegan T; Zamanillo D; Vela JM; Maldonado R
    Eur J Pain; 2013 Jul; 17(6):832-43. PubMed ID: 23172791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
    Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
    Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transient allodynia pain models in mice for early assessment of analgesic activity.
    Gil DW; Cheevers CV; Donello JE
    Br J Pharmacol; 2008 Feb; 153(4):769-74. PubMed ID: 17700719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of Novel Alkoxyisoxazoles as Sigma-1 Receptor Antagonists with Antinociceptive Efficacy.
    Sun H; Shi M; Zhang W; Zheng YM; Xu YZ; Shi JJ; Liu T; Gunosewoyo H; Pang T; Gao ZB; Yang F; Tang J; Yu LF
    J Med Chem; 2016 Jul; 59(13):6329-43. PubMed ID: 27309376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of vinylcycloalkyl-substituted benzimidazole TRPM8 antagonists effective in the treatment of cold allodynia.
    Calvo RR; Meegalla SK; Parks DJ; Parsons WH; Ballentine SK; Lubin ML; Schneider C; Colburn RW; Flores CM; Player MR
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1903-7. PubMed ID: 22330635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel highly potent and selective sigma 1 receptor antagonists related to spipethiane.
    Piergentili A; Amantini C; Del Bello F; Giannella M; Mattioli L; Palmery M; Perfumi M; Pigini M; Santoni G; Tucci P; Zotti M; Quaglia W
    J Med Chem; 2010 Feb; 53(3):1261-9. PubMed ID: 20067271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.